• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ROCHE DIAGNOSTICS ELECSYS ANTI-SARS-COV-2; CORONAVIRUS SEROLOGICAL REAGENT Back to Search Results
Catalog Number 09203095190
Device Problem False Positive Result (1227)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 05/07/2020
Event Type  malfunction  
Manufacturer Narrative
The qc and calibrations were within acceptable limits.The euroimmun iga-assay is not on the list of eua (emergency use authorization) products.This event occurred in (b)(6).The investigation is ongoing.
 
Event Description
The initial reporter received questionable elecsys anti-sars-cov-2 results for 1 positive covid-19 patient on a cobas 6000 e601 module, serial number (b)(4).On (b)(6) 2020, the patient sample produced a positive result of 1.08 coi using the elecsys anti-sars-cov-2 method.The sample was retested on a different analyzer using the same method.The sample produced another positive result of 1.48 coi.The same sample was tested using the euroimmun iga-assay and produced a negative result of 0.43 coi.The same sample was tested using the euroimmun igg-assay and produced a negative result of 0.34 coi.The same sample was also tested using the diasorin igg-assay and the sample produced a result of < 0.43 coi.The results were not reported outside of the laboratory.It is unknown which results are believed to be correct.
 
Manufacturer Narrative
The customer's sample was returned for investigation.The customer's result for the sample was reproducible with the elecsys anti-sars-cov-2 assay.Additional measurements were performed with a rapid assay from creative diagnostics as well as an independent in-house roche assay detecting other antibodies against sars-cov-2.A weak igm reactivity was detected in the rapid assay, whereas igg resulted non-reactive.Similarly, the roche in-house assay showed weak reactivity, however, below the cutoff level.Based on the available data, a general reagent issue could be excluded.The investigation did not identify a product problem.The cause of the event could not be determined.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
ELECSYS ANTI-SARS-COV-2
Type of Device
CORONAVIRUS SEROLOGICAL REAGENT
Manufacturer (Section D)
ROCHE DIAGNOSTICS
9115 hague road
indianapolis IN 46250 0457
MDR Report Key10242046
MDR Text Key202550156
Report Number1823260-2020-01627
Device Sequence Number1
Product Code QKO
Combination Product (y/n)N
PMA/PMN Number
EXEMPT
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type foreign,health professional,u
Type of Report Initial,Followup
Report Date 08/21/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received07/07/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/30/2020
Device Catalogue Number09203095190
Device Lot Number49629801
Was Device Available for Evaluation? Device Returned to Manufacturer
Date Returned to Manufacturer06/18/2020
Date Manufacturer Received06/08/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
-
-